These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7535564)
1. Conformational transitions in the cell binding domain of fibronectin. Ugarova TP; Zamarron C; Veklich Y; Bowditch RD; Ginsberg MH; Weisel JW; Plow EF Biochemistry; 1995 Apr; 34(13):4457-66. PubMed ID: 7535564 [TBL] [Abstract][Full Text] [Related]
2. Matrix-driven translocation: dependence on interaction of amino-terminal domain of fibronectin with heparin-like surface components of cells or particles. Newman SA; Frenz DA; Hasegawa E; Akiyama SK Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4791-5. PubMed ID: 2440029 [TBL] [Abstract][Full Text] [Related]
3. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093 [TBL] [Abstract][Full Text] [Related]
4. Borrelia burgdorferi protein BBK32 binds to soluble fibronectin via the N-terminal 70-kDa region, causing fibronectin to undergo conformational extension. Harris G; Ma W; Maurer LM; Potts JR; Mosher DF J Biol Chem; 2014 Aug; 289(32):22490-9. PubMed ID: 24962582 [TBL] [Abstract][Full Text] [Related]
5. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
6. Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. Hocking DC; Sottile J; McKeown-Longo PJ J Biol Chem; 1994 Jul; 269(29):19183-7. PubMed ID: 8034677 [TBL] [Abstract][Full Text] [Related]
7. Binding of fibronectin and its proteolytic fragments to glycosaminoglycans. Exposure of cryptic glycosaminoglycan-binding domains upon limited proteolysis. Sekiguchi K; Hakomori S; Funahashi M; Matsumoto I; Seno N J Biol Chem; 1983 Dec; 258(23):14359-65. PubMed ID: 6643486 [TBL] [Abstract][Full Text] [Related]
8. Ligation of the fibrin-binding domain by β-strand addition is sufficient for expansion of soluble fibronectin. Maurer LM; Ma W; Eickstaedt NL; Johnson IA; Tomasini-Johansson BR; Annis DS; Mosher DF J Biol Chem; 2012 Apr; 287(16):13303-12. PubMed ID: 22351755 [TBL] [Abstract][Full Text] [Related]
9. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. Bultmann H; Santas AJ; Peters DM J Biol Chem; 1998 Jan; 273(5):2601-9. PubMed ID: 9446562 [TBL] [Abstract][Full Text] [Related]
10. Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Pierschbacher MD; Hayman EG; Ruoslahti E Cell; 1981 Oct; 26(2 Pt 2):259-67. PubMed ID: 6174240 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to the collagen binding domain of human plasma fibronectin. Tarone G; Amedeo MR; Di Renzo MF; Comoglio P Exp Cell Biol; 1984; 52(4):225-36. PubMed ID: 6203785 [TBL] [Abstract][Full Text] [Related]
12. Two novel monoclonal antibodies to fibronectin that recognize the Hep II and CS-1 regions respectively: their differential effect on lymphocyte adhesion. Garcia-Pardo A; Sánchez-Aparicio P; Wayner EA Biochem Biophys Res Commun; 1992 Jul; 186(1):135-42. PubMed ID: 1378720 [TBL] [Abstract][Full Text] [Related]
13. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. Carnemolla B; Leprini A; Allemanni G; Saginati M; Zardi L J Biol Chem; 1992 Dec; 267(34):24689-92. PubMed ID: 1280266 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. Nagai T; Yamakawa N; Aota S; Yamada SS; Akiyama SK; Olden K; Yamada KM J Cell Biol; 1991 Sep; 114(6):1295-305. PubMed ID: 1716636 [TBL] [Abstract][Full Text] [Related]
15. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains. Click EM; Balian G Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623 [TBL] [Abstract][Full Text] [Related]
16. Fine mapping of inhibitory anti-alpha5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Burrows L; Clark K; Mould AP; Humphries MJ Biochem J; 1999 Dec; 344 Pt 2(Pt 2):527-33. PubMed ID: 10567237 [TBL] [Abstract][Full Text] [Related]
17. Identification with monoclonal antibodies of different regions of human plasma fibronectin, including that which interacts with human monocyte fibronectin receptors. Czop JK; Kadish JL; Zepf DM; Austen KF Immunology; 1985 Mar; 54(3):407-17. PubMed ID: 2579023 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of a murine monoclonal antibody against the repetitive region of the fibronectin-binding adhesins fibronectin-binding protein A and fibronectin-binding protein B from Staphylococcus aureus. Provenza G; Provenzano M; Visai L; Burke FM; Geoghegan JA; Stravalaci M; Gobbi M; Mazzini G; Arciola CR; Foster TJ; Speziale P FEBS J; 2010 Nov; 277(21):4490-505. PubMed ID: 20875085 [TBL] [Abstract][Full Text] [Related]
19. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816 [TBL] [Abstract][Full Text] [Related]
20. Distinct regions of human fibronectin are essential for fibril assembly in an in vivo developing system. Darribère T; Koteliansky VE; Chernousov MA; Akiyama SK; Yamada KM; Thiery JP; Boucaut JC Dev Dyn; 1992 May; 194(1):63-70. PubMed ID: 1421520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]